Close Menu

NEW YORK (GenomeWeb News) – Clinical Data today reported that its first-quarter revenues increased 81 percent year over year, due to sales growth for its Familion genetic tests.

The Newton, Mass.-based drug and pharmacogenomic test developer brought in total revenues of $3.7 million for the three-month period ended June 30, compared with revenues of $2 million for the first quarter of 2008. Its revenues came from sales of its Familion genetic tests, which are sold by its PGx Health division.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.